Homing of in vitro-generated donor antigen-reactive CD4+ T lymphocytes to renal allografts is α4β1 but not αLβ2 integrin dependent

被引:10
作者
Hammer, MH
Zhai, Y
Katori, M
Ritter, T
Volk, HD
Coito, AJ
Kupiec-Weglinski, JW
机构
[1] Univ Calif Los Angeles, Sch Med, Dept Surg, Dumont UCLA Transplant Ctr, Los Angeles, CA 90095 USA
[2] Humboldt Univ, Charite, Inst Med Immunol, Berlin, Germany
关键词
D O I
10.4049/jimmunol.166.1.596
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The extravasation and sequestration of Ag-reactive T lymphocytes into vascularized organ allografts depend on a cascade of complex interactions among circulating lymphocytes, endothelial cells, and extracellular matrix proteins, Ag-activated donor-specific CD4 T cells are major initiators and effecters in the allograft rejection response. Interfering with the intragraft homing of activated CD4 T cells may represent a novel therapeutic approach in transplant recipients. We have developed a FAGS-based short-term homing assay that allows tracing in vitro-generated Ag-reactive CD4 T cells after adoptive transfer in test rat recipients. Allospecific cell lines were preincubated with anti-alpha (4)beta (1) or anti-alpha (L)beta (2) mAb, because of enhanced expression of both integrin receptors after alloactivation, The pretreated Lewis(BN) lymphocytes were carboxyfluorescein diacetate succinimidyl ester labeled and adoptively transferred into Lewis rat recipients of Brown Norway kidney allografts, The injection of equal numbers of PKH-26-labeled untreated cells allowed quantitative comparison of both populations in the same animal. Ex vivo treatment with anti-alpha (4)beta (1) mAb diminished intragraft infiltration of adoptively transferred T cells by 85% in a donor-specific fashion, In contrast, treatment with anti-alpha (L)beta (2) mAb did not affect intragraft cell sequestration. Hence, blocking alpha (4)beta (1) integrin interactions represents a novel strategy in preventing local intragraft recruitment of Ag-reactive CD4 T cells in transplant recipients.
引用
收藏
页码:596 / 601
页数:6
相关论文
共 32 条
[1]   THE INTEGRIN VLA-4 SUPPORTS TETHERING AND ROLLING IN FLOW ON VCAM-1 [J].
ALON, R ;
KASSNER, PD ;
CARR, MW ;
FINGER, EB ;
HEMLER, ME ;
SPRINGER, TA .
JOURNAL OF CELL BIOLOGY, 1995, 128 (06) :1243-1253
[2]   Antibodies to CD44 and integrin α4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment [J].
Brocke, S ;
Piercy, C ;
Steinman, L ;
Weissman, IL ;
Veromaa, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) :6896-6901
[3]   Fibronectin-mononuclear cell interactions regulate type 1 helper T cell cytokine network in tolerant transplant recipients [J].
Coito, AJ ;
Onodera, K ;
Kato, H ;
Busuttil, RW ;
Kupiec-Weglinski, JW .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (04) :1207-1218
[4]   Blockade of very late antigen-4 integrin binding to fibronectin in allograft recipients - I. Treatment with connecting segment-1 peptides prevents acute rejection by suppressing intragraft mononuclear cell accumulation, endothelial activation, and cytokine expression [J].
Coito, AJ ;
Korom, S ;
Graser, E ;
Volk, HD ;
Van de Water, L ;
Kupiec-Weglinski, JW .
TRANSPLANTATION, 1998, 65 (05) :699-706
[5]  
DAMLE NK, 1992, J IMMUNOL, V148, P1985
[6]   EVIDENCE THAT HUMAN CARDIAC ALLOGRAFT ACCEPTANCE IS ASSOCIATED WITH A DECREASE IN DONOR-REACTIVE HELPER T-LYMPHOCYTES [J].
DEBRUYNE, LA ;
RENLUND, DG ;
BISHOP, DK .
TRANSPLANTATION, 1995, 59 (05) :778-783
[7]   LYSIS OF RAT-BRAIN MICROVASCULAR ENDOTHELIAL-CELLS MEDIATED BY RESTING BUT NOT ACTIVATED MBP-SPECIFIC CD4(+) T-CELL LINES [J].
ENGELHARDT, B ;
GORLACH, H ;
RISAU, W ;
WEKERLE, H .
JOURNAL OF NEUROIMMUNOLOGY, 1994, 55 (01) :69-80
[8]   2 INTEGRIN-BINDING PEPTIDES ABROGATE T-CELL-MEDIATED IMMUNE-RESPONSES INVIVO [J].
FERGUSON, TA ;
MIZUTANI, H ;
KUPPER, TS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (18) :8072-8076
[9]  
Geginat J, 2000, EUR J IMMUNOL, V30, P1136, DOI 10.1002/(SICI)1521-4141(200004)30:4<1136::AID-IMMU1136>3.0.CO
[10]  
2-3